25
Views
1
CrossRef citations to date
0
Altmetric
Expert Opinion

Current issues and perspectives in prenatal nutrition

, , , &
Pages 25-38 | Published online: 25 May 2011

References

  • Scholl TO. Maternal nutrition before and during pregnancy. Nestle Nutr Workshop Ser Pediatr Program. 2008;61:79–89.
  • Kaiser LL, Allen L. American Dietetic Association. Position of the American Dietetic Association: Nutrition and lifestyle for a healthy pregnancy outcome. J Am Diet Assoc. 2002;102:1479–1490.
  • The American College of Obstetricians and Gynecologists. Nutrition During Pregnancy. ACOG pamphlet number AP001. Available from: http://www.acog.org/publications/patient_education/bp001.cfm. Accessed January 25, 2011.
  • Kontic-Vucinic O, Sulovic N, Radunovic N. Micronutrients in women’s reproductive health: I. Vitamins. Int J Fertil Womens Med. 2006;51: 106–115.
  • Picciano MF, McGuire MK. Use of dietary supplements by pregnant and lactating women in North America. Am J Clin Nutr. 2009;89 Suppl:663S-667S.
  • Wilson RD, Johnson JA, Wyatt P, et al. Pre-conceptional vitamin/folic acid supplementation 2007: The use of folic acid in combination with a multivitamin supplement for the prevention of neural tube defects and other congenital anomalies. J Obstet Gynaecol Can. 2007;29:1003–1006.
  • Goh YI, Bollano E, Einarson TR, Koren G. Prenatal multivitamin supplementation and rates of congenital anomalies: A meta-analysis. J Obstet Gynaecol Can. 2006;28:680–689.
  • Daly S, Mills JL, Molloy AM, et al. Minimum effective dose of folic acid for food fortification to prevent neural-tube defects. Lancet. 1997;350:1666–1669.
  • Wald NJ, Law MR, Morris JK, Wald DS. Quantifying the effect of folic acid. Lancet. 2001;358:2069–2073.
  • National Institutes of Health: Office of Dietary Supplements. Dietary supplement fact sheet: Folate. Available from: http://dietary-supplements.info.nih.gov/factsheets/folate.asp. Accessed January 25, 2011.
  • Reynolds EH. Mental effects of anticonvulsants and folic acid metabolism. Brain. 1968;91:197–214.
  • Lamers Y, Prinz-Langenohl R, Brämswig S, Pietrzik K. Red blood cell folate concentrations increase more after supplementation with [6S]-5-methyltetrahydrofolate than with folic acid in women of childbearing age. Am J Clin Nutr. 2006;84:156–161.
  • Daly LE, Kirke PN, Molloy A, Weir DG, Scott JM. Folate levels and neural tube defects. Implications for prevention. JAMA. 1995;274: 1698–1702.
  • Venn BJ, Green TJ, Moser R, McKenzie JE, Skeaff CM, Mann J. Increases in blood folate indices are similar in women of childbearing age supplemented with [6S]-5-methyltetrahydrofolate and folic acid. J Nutr. 2002;132:335–5.
  • American Academy of Pediatrics Committee on Genetics. Folic acid for the prevention of neural tube defects. Pediatrics. 1999;104: 325–327.
  • Carlson SE. Docosahexaenoic acid supplementation in pregnancy and lactation. Am J Clin Nutr. 2009;89 Suppl:678S-684S.
  • Jensen CL, Voigt RG, Llorente AM, et al. Effects of early maternal docosahexaenoic acid intake on neuropsychological status and visual acuity at five years of age of breast-fed term infants. J Pediatr. 2010;157:900–905.
  • Hadders-Algra M. Prenatal long-chain polyunsaturated fatty acid status: The importance of a balanced intake of docosahexaenoic acid and arachidonic acid. J Perinat Med. 2008;36:101–109.
  • Makrides M, Gibson RA, McPhee AJ, et al. Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children. JAMA. 2010;304:1675–1683.
  • van Goor SA, Janneke Dijck-Brouwer DA, Ershch JJ, Schaafsma A, Hadders-Algra M. The influence of supplemental docosahexaenoic and arachidonic acids during pregnancy and lactation on neurodevelopment at eighteen months. Prostaglandins Leukot Essent Fatty Acids. 2011;84:139–146.
  • Stein AD, Wang M, Martorell R, et al. Growth to age 18 months following prenatal supplementation with docosahexaenoic acid differs by maternal gravidity in Mexico. J Nutr. 2011;141:316–320.
  • Ramakrishnan U, Stein AD, Parra-Cabrera S, et al. Effects of docosa-hexaenoic acid supplementation during pregnancy on gestational age and size at birth: Randomized, double-blind, placebo-controlled trial in Mexico. Food Nutr Bull. 2010;31 Suppl 2:S108–S116.
  • Simopoulos AP, Leaf A, Salem N Jr. Workshop on the essentiality of and recommended dietary intakes (RDI) for omega-6 and omega-3 fatty acids. April 7–9, 1999; Bethesda, MD. Available from: http://www.issfal.org/index.php/archive-mainmenu-14/adequate-intakes-mainmenu-50. Accessed April 14, 2011.
  • Koletzko B, Lien E, Agostoni C, et al. The roles of long-chain polyunsaturated fatty acids in pregnancy, lactation and infancy: Review of current knowledge and consensus recommendations. J Perinat Med. 2008;36:5–14.
  • Koletzko B, Cetin I, Brenna JT, et al. Dietary fat intakes for pregnant and lactating women. Br J Nutr. 2007;98:873–877.
  • Arterburn LM, Oken HA, Bailey Hall E, et al. Algal-oil capsules and cooked salmon: Nutritionally equivalent sources of docosahexaenoic acid. J Am Diet Assoc. 2008;108:1204–1209.
  • Visioli F, Rise P, Barassi MC, Marangoni F, Galli C. Dietary intake of fish vs formulations leads to higher plasma concentrations of n-3 fatty acids. Lipids. 2003;38:415–418.
  • Cannon D. From fish oil to microalgae oil. A win-win shift for humans and our habitat. Explore. 2009;5:299–303.
  • Doughman SD, Krupanidhi S, Sanjeevi CB. Omega-3 fatty acids for nutrition and medicine: Considering microalgae oil as a vegetarian source of EPA and DHA. Curr Diabetes Rev. 2007;3:198–203.
  • Brigham and Women’s Hospital. Fish oil, omega-3 fatty acids. Available from: http://healthlibrary.brighamandwomens.org/Library/Drug Reference/26,2722?PrinterFriend. Accessed January 25, 2011.
  • MedlinePlus. Fish oil. Available from: http://www.nlm.nih.gov/medlineplus/druginfo/natural/993.html. Accessed January 25, 2011.
  • Schwellenbach LJ, Olson KL, McConnell KJ, et al. The triglyceridelowering effects of a modest dose of docosahexaenoic acid alone versus in combination with low dose eicosapentaenoic acid in patients with coronary artery disease and elevated triglycerides. J Am Coll Nutr. 2006;25:480–485.
  • Casanueva E, Viteri FE. Iron and oxidative stress in pregnancy. J Nutr. 2003;(5 Suppl 2)133:1700S-1708S.
  • Agarwal A, Gupta S, Sharma RK. Role of oxidative stress in female reproduction. Reprod Biol Endocrinol. 2005;3:28.
  • Henson MC, Chedrese PJ. Endocrine disruption by cadmium, a common environmental toxicant with paradoxical effects on reproduction. Exp Biol Med. 2004;229:383–392.
  • Buhimschi IA, Buhimschi CS, Pupkin M, Weiner CP. Beneficial impact of term labor: Nonenzymatic antioxidant reserve in the human fetus. Am J Obstet Gynecol 2003;189:181–188.
  • American Pregnancy Association, Statistics. Available from: http://www.americanpregnancy.org/main/statistics.html. Accessed January 25, 2011.
  • Newton ER. Preterm labor, preterm premature rupture of membranes, and chorioamnionitis. Clin Perinatol. 2005;32:571–600.
  • Furman B, Shoham-Vardi I, Bashiri A, Erez O, Mazor M. Clinical significance and outcome of preterm prelabor rupture of membranes: Population-based study. Eur J Obstet Gynecol Reprod Biol. 2000;92:209–216.
  • Hawfield A, Freedman BI. Pre-eclampsia: The pivotal role of the placenta in its pathophysiology and markers for early detection. Ther Adv Cardiovasc Dis. 2009;3:65–73.
  • National Heart and Lung Blood Institute. Working Group Report on High Blood Pressure in Pregnancy. Available from: http://www.nhlbi.nih.gov/guidelines/archives/hbp_preg/hbp_preg_archive.pdf. Accessed on March 17, 2009.
  • Sibai BM. Diagnosis and management of gestational hypertension and preeclampsia. Obstet Gynecol. 2003;102:181–192.
  • Endemann DH, Schiffrin EL. Endothelial dysfunction. J Am Soc Nephrol. 2004;15:1983–1992.
  • Myatt L, Webster RP. Vascular biology of preeclampsia. J Thromb Haemost. 2009;7:375–384.
  • Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet. 2005;365:785–799.
  • Mutter WP, Karumanchi SA. Molecular mechanisms of preeclampsia. Microvasc Res. 2008;75:1–8.
  • MacKay AP, Berg CJ, Atrash HK. Pregnancy-related mortality from preeclampsia and eclampsia. Obstet Gynecol. 2001;97:533–538.
  • Roberts JM, Hubel CA. Is oxidative stress the link in the two-stage model of pre-eclampsia? Lancet. 1999;354:788–789.
  • Ouyang YQ, Li SJ, Zhang Q, Cai HB, Chen HP. Interactions between inflammatory and oxidative stress in preeclampsia. Hypertens Pregnancy. 2009;28:56–62.
  • Roberts JM, Speer P. Antioxidant therapy to prevent preeclampsia. Semin Nephrol. 2004;24:557–564.
  • Goldenberg RL, Culhane JF, Iams JD, Romero R. Epidemiology and causes of preterm birth. Lancet. 2008;371:75–84.
  • Robertson PA, Sniderman SH, Laros RK Jr, et al. Neonatal morbidity according to gestational age and birth weight from five tertiary care centers in the United States, 1983 through 1986. Am J Obstet Gynecol. 1992;166:1629–1645.
  • Denney JM, Culhane JL, Goldenberg RL. Prevention of preterm birth. Womens Health (Lond Engl). 2008;4:625–638.
  • Juh YJ, Kim YJ, Park H, Park EA, Ha EH. Oxidative stress-related gene interactions with preterm delivery in Korean women. Am J Obstet Gynecol. 2008;198;541:e1-e7.
  • Peter Stein T, Scholl TO, Schluter MD, et al. Oxidative stress early in pregnancy and pregnancy outcome. Free Radic Res. 2008;42: 841–848.
  • Cinkaya A, Keskin HL, Buyukkagnici U, et al. Maternal plasma total antioxidant status in preterm labor. J Obstet Gynaecol Res. 2010;36: 1185–1188.
  • Joshi SR, Mehendale SS, Dangat KD, Kilari AS, Yadav HR, Taralekar VS. High maternal plasma antioxidant concentrations associated with preterm delivery. Ann Nutr Metab. 2008;53:276–282.
  • Burton GJ, Jauniaux E. Oxidative stress. Best Pract Res Clin Obstet Gynaecol. December 2, 2010. [Epub ahead of print].
  • Roberts JM, Myatt L, Spong CY, et al. Vitamins C and E to prevent complications of pregnancy-associated hypertension. N Engl J Med. 2010;362:1282–1291.
  • Spinnato JA 2nd, Freire S, Pinto E, et al. Antioxidant therapy to prevent preeclampsia: A randomized controlled trial. Obstet Gynecol. 2007;110:1311–1318.
  • Poston L, Briley AL, Seed PT, Kelly FJ, Shennan AH. Vitamins in Pre-eclampsia VIP Trial Consortium. Vitamin C and vitamin E in pregnant women at risk for pre-eclampsia (VIP trial): Randomized placebo-controlled trial. Lancet. 2006;367:1145–1154.
  • Rahimi R, Nikfar S, Rezaie A, Abdollahi M. A meta-analysis on the efficacy and safety of combined vitamin C and E supplementation in preeclamptic women. Hypertens Pregnancy. 2009;28:417–434.
  • Crane FL, Navas P. The diversity of coenzyme Q function. Mol Aspects Med. 1997;18 Suppl:S1-S6.
  • Teran E, Racines-Orbe M, Vivero S, Escudero C, Molina G, Calle A. Preeclampsia is associated with a decrease in plasma coenzyme Q10 levels. Free Radic Biol Med. 2003;35:1453–1456.
  • Pravst I, Zmitek K, Zmitek J. Coenzyme Q10 contents in foods and fortification strategies. Crit Rev Food Sci Nutr. 2010;50:269–280.
  • Hidaka T, Fujii K, Funahashi I, Fukutomi N, Hosoe K. Safety assessment of coenzyme Q10 (CoQ10). Biofactors. 2008;32:199–208.
  • Teran E, Hernandez I, Nieto B, Tavara R, Ocampo JE, Calle A. Coenzyme Q10 supplementation during pregnancy reduces the risk of pre-eclampsia. Int J Gynaecol Obstet. 2009;105:43–45.
  • Quiles JL, Ochoa JJ, Ramirez-Tortosa MC, et al. Coenzyme Q concentration and total antioxidant properties of human milk at different stages of lactation in mothers of preterm and full-term infants. Free Radic Res. 2006;40:199–206.
  • Teran E, Vivero S, Racines-Orbe M, et al. Coenzyme Q10 is increased in placenta and cord blood during preeclampsia. Biofactors. 2005;25:153–158.
  • Palan PR, Shaban DW, Martino T, Mikhail MS. Lipid-soluble antioxidants and pregnancy: Maternal serum levels of coenzyme Q10, alpha-tocopherol and gamma-tocopherol in preeclampsia and normal pregnancy. Gynecol Obstet Invest. 2004;58:8–13.
  • Haruna M, Matsuzaki M, Ota E, et al. Positive correlation between maternal serum coenzyme Q10 levels and infant birth weight. Biofactors. 2010;36:312–318.
  • Landmesser U, Merten R, Spiekermann S, Büttner K, Drexler H, Hornig B. Vascular extracellular superoxide dismutase activity in patients with coronary artery disease: Relation to endothelium-dependent vasodilation. Circulation. 2000;101:2264–2270.
  • Tiano L, Belardinelli R, Carnevali P, Principi F, Seddaiu G, Littarru GP. Effect of coenzyme Q10 administration on endothelial function and extracellular superoxide dismutase in patients with ischaemic heart disease: A double-blind, randomized controlled study. Eur Heart J. 2007;28:2249–2255.
  • Sharma JB, Kumar A, Kumar A, et al. Effect of lycopene on preeclampsia and intra-uterine growth retardation in primigravidas. Int J Gynaecol Obstet. 2003;81:257–262.
  • Kramer MS, Kahn SR, Platt RW, et al. Antioxidant vitamins, long-chain fatty acids, and spontaneous preterm birth. Epidemiology. 2009;20: 707–713.
  • Clinton SK. Lycopene: Chemistry, biology, and implications for human health and disease. Nutr Rev. 1998;56:35–51.
  • Di Mascio P, Kaiser S, Sies H. Lycopene as the most efficient biological carotenoid singlet oxygen quencher. Arch Biochem Biophys. 1989; 274:532–538.
  • Tsugane S, Tsuda M, Gey F, Watanabe S. Cross-sectional study with multiple measurements of biological markers for assessing stomach cancer risks at the population level. Environ Health Perspect. 1992; 98:207–210.
  • Van Eenwyck J, Davis FG, Bowen PE. Dietary and serum carotenoids and cervical intraepithelial neoplasia. Int J Cancer. 1991;48:34–38.
  • Garland M, Willett WC, Manson JE, Hunter DJ. Antioxidant micronutrients and breast cancer. J Am CollNutr. 1993;12:400–411.
  • Ribayo-Mercado JD, Garmyn M, Gilchrest BA, Russell RM. Skin lyco-pene is destroyed preferentially over beta-carotene during ultraviolet irradiation in humans. J Nutr. 1995;125:1854–1859.
  • Helzlsouer KJ, Comstock GW, Morris JS. Selenium, lycopene, alfa-tocopherol, beta-carotene, retinol, and subsequent bladder cancer. Cancer Res. 1989;49:6144–6148.
  • Giovannucci E, Ascherio A, Rimm EB, Stampfer MJ, Colditz GA, Willett WC. Intake of carotenoids and retinol in relation to risk of prostate cancer. J Natl Cancer Inst. 1995;87:1767–1776.
  • Frei B. Cardiovascular disease and nutrient antioxidants: Role of low-density lipoprotein oxidation. Crit Rev Food Sci Nutr. 1995;35(1–2): 83–98.
  • Erdman JW Jr, Ford NA, Lindshield BL. Are the health attributes of lycopene related to its antioxidant function? Arch Biochem Biophys. 2009;483:229–235.
  • Banerjee S, Jeyaseelan S, Guleria R. Trial of lycopene to prevent preeclampsia in healthy primigravidas: Results show some adverse effects. J Obstet Gynecol. 2009;35(3):477–482.
  • Trumbo PR. Are there adverse effects of lycopene exposure? J Nutr. 2005;135:2060S–2061S.
  • Alien CM, Smith AM, Clinton SK, Schwartz SJ. Tomato consumption increases lycopene isomer concentrations in breast milk and plasma of lactating women. J Am Diet Assoc. 2002;102:1257–1262.
  • PreQue™ 10 [Package insert]. Ashland, VA: Atley Pharmaceuticals Inc; 2009.
  • OB Complete 400 [Package insert]. Sayreville, NJ: Vertical Pharmaceuticals Inc; 2009.
  • PreNexa Capsules [Package insert]. Maple Grove, MN: Upsher-Smith Laboratories Inc; 2008.
  • Prenate DHA [Package insert]. Atlanta, GA: Sciele Pharma Inc; 2008.
  • Vitafol-OB + DHA Caplets [Package insert]. Available at: http://www.everettlabs.com/ever2/vitafol_ob_dha.asp. Accessed February 7, 2011.
  • CitraNatal Assure [Package insert]. San Antonio, TX: Mission Pharmacal; 2009.
  • Gesticare DHA [Package insert]. Dublin, Ireland: Azur Pharma Inc; 2001.
  • OB Complete™ One [Package insert]. Sayreville, NJ: Vertical Pharmaceuticals Inc; 2010.
  • Prenate Essential™ [Package insert]. Atlanta, GA: Shionogi Pharma Inc; 2010.
  • CitraNatal® Harmony™ [Package insert]. San Antonio, TX: Mission Pharmacal; 2010.
  • PreferaOB ONE™ [Package insert]. Marietta, GA: Alaven Pharmaceuticals; 2010.
  • NeevoDHA® [Package insert]. Covington, LA: Pamlab; 2009.
  • Concept DHA™ [Package insert]. Decatur, GA: US Pharmaceutical Corp; 2010.
  • Minnesota Department of Health. Bayley Scales of Infant and Toddler Development. (BAYLEY-III). 3rd ed. Available from: www.pearsonassessments.com/HAIWEB/Cultures/en-us/Productdetail.htm?Pid=015–8027–23X. Accessed May 4, 2011.